Literature DB >> 15454775

Assessment of salivary flow rate: biologic variation and measure error.

Peter H Jongerius1, Jacques van Limbeek, Jan J Rotteveel.   

Abstract

OBJECTIVE: To investigate the applicability of the swab method in the measurement of salivary flow rate in multiple-handicap drooling children. To quantify the measurement error of the procedure and the biologic variation in the population. STUDY
DESIGN: Cohort study.
METHODS: In a repeated measurements design, a baseline series of salivary flow rates were obtained from 45 children. The within-subject SD (SW) was calculated to express the measurements error according to a procedure introduced by Bland and Altman.
RESULTS: Two hundred twenty-four samples (mean 0.40 mL/min, SD 0.19 mL/min) were obtained and analyzed. The results of this study indicate that consistent scores were obtained at subsequent measurements, and good parity existed between the two measurements of salivary flow rate at each session. The SW could be estimated (0.11 mL/min), which was applied to quantify the specific variation of the salivary flow rate in our population.
CONCLUSION: According to Bland and Altman, the SW, which is a quantification of the measurement error and biologic variation, was found to be a useful tool to evaluate the obtained baseline salivary flow rate measurements. The swab method can be used to evaluate salivary flow rates in drooling children with cerebral palsy during interventional studies that aim to reduce saliva production.

Entities:  

Mesh:

Year:  2004        PMID: 15454775     DOI: 10.1097/00005537-200410000-00023

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

Review 1.  Clozapine-induced sialorrhea: pathophysiology and management strategies.

Authors:  Samir Kumar Praharaj; Manu Arora; Sachin Gandotra
Journal:  Psychopharmacology (Berl)       Date:  2006-03-03       Impact factor: 4.530

2.  Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients.

Authors:  Marta Lavrador; Ana C Cabral; Isabel V Figueiredo; Manuel T Veríssimo; M Margarida Castel-Branco; Fernando Fernandez-Llimos
Journal:  Int J Clin Pharm       Date:  2020-08-29

Review 3.  Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management.

Authors:  Marcelo Merello
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

4.  Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study.

Authors:  Eigild Møller; Søren Anker Pedersen; Pablo Gustavo Vinicoff; Allan Bardow; Joan Lykkeaa; Pia Svendsen; Merete Bakke
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

5.  Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.

Authors:  Dai Shi; Jian-Jun Qian; Guo-Hua Fan; Jun-Kang Shen; Ye Tian; Liang Xu
Journal:  BMC Oral Health       Date:  2019-12-21       Impact factor: 2.757

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.